|
Amersham™ ECL™ detection systems
|
| Amersham ECL Western Blotting Systems from GE Healthcare have been delivering sensitivity, speed, and versatility since 1990. Today, the world’s first chemiluminescent reagents continue to be the most widely used and have established a well-earned reputation for excellence you can rely on, day in, day out.
1990
Amersham ECL makes nonradioactive protein detection possible for the first time.
1997
Amersham ECL Plus introduces flexible chemiluminescent and chemifluorescent detection for Western blotting.
2002
Amersham ECL Advance™ dramatically decreases primary antibody consumption, enabling efficient use of expensive or scarce reagents.
| |
2005
Amersham ECL Plex™ brings multiplex, quantitative fluorescent analysis to 1-D and 2-D gels, enabling faster detection and better resolution of protein targets with identical molecular weights.
2010
Amersham ECL Prime, optimal with CCD based detection systems and the latest addition to the ECL family, bringing outstanding sensitivity and quantitative performance to Western blotting.
|
|
